Brief: Kane Biotech Announces Fourth Quarter And Full Year 2021 Financial Results
24/03/2022 20:45
March 24 (Reuters) - Kane Biotech Inc KNE.V :
* KANE BIOTECH ANNOUNCES FOURTH QUARTER AND FULL YEAR 2021
FINANCIAL RESULTS
* KANE BIOTECH INC - QTRLY TOTAL REVENUE $411,693, AN
INCREASE OF
60% COMPARED TO $257,339 FOR THREE MONTHS ENDED DECEMBER 30,
2020
* KANE BIOTECH INC - QTRLY BASIC AND DILUTED LOSS PER SHARE
FOR
PERIOD $0.01
Source text for Eikon: ID:nGNX2jbMCQ
Further company coverage: KNE.V
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Kane Biotech
See all newsBrief: Kane Biotech Announces FDA 510(K) Clearance For Revyve® Antimicrobial Skin And Wound Cleanser
Brief: Kane Biotech Restarts Commercial Activities And Strengthens North American Management
Brief: Kane Biotech Completes U.S. FDA 510(K) Submission For Revyve Antimicrobial Wound Cleanser
Brief: Kane Biotech Announces Second Quarter 2025 Financial Results
Brief: Kane Biotech provides further corporate update